| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1427635 | Journal of Controlled Release | 2006 | 6 Pages |
An intragastric buoyant sustained-release tablet (IGB-T) containing 100 mg of amoxicillin (AMX) was prepared to eradicate gastric Helicobacter pylori. A tablet prepared by compressing the mixture of hydroxypropylcellulose-H (HPC-H), citric acid (17.2 mg), sodium hydrogen carbonate (22.8 mg) and AMX was employed as the basic system for preparing IGB-T. The weight and diameter of the tablets were designed to be about 300 mg and 10 mm, respectively. IGB-T containing 5 mg of AMX and HPC-H (255 mg) was buoyant and showed a sustained-release pattern in water. However, when AMX was increased and HPC-H decreased to maintain the tablet weight (300 mg), there was no apparent sustained-release pattern. To prepare IGB-T containing 50 mg of AMX, the surface of the tablet was coated with HPC-H after a tablet was prepared from the mixture of AMX (50 mg), HPC-H (210 mg), citric acid (17.2 mg), and sodium hydrogen carbonate (22.8 mg). This tablet (IGB-T50-Coating) was buoyant and showed a sustained-release pattern in water. However, to complete IGB-T with 100 mg of AMX, it was necessary not only to coat the surface of the tablet but also to use granulated AMX with a particle size of 300–500 μm (IGB-T100-Coating-300-500G). IGB-T100-Coating-300-500G was confirmed to be buoyant for 24 h while maintaining a tablet shape and showed a sustained-release pattern in water and buffer solutions of pH 1.2 and 6.8.
